About Ceres Pharma
Ceres Pharma is a Healthcare company based in Merelbeke (Belgium) founded in 2017 by Marc Coucke and Mario Debel, and was acquired by Naxicap in June 2021. Nutritional supplements are manufactured and marketed by Ceres Pharma. The company has 31 employees. Ceres Pharma has completed 4 acquisitions, including AMNOL, Aesculapius and Ceumed. Its chief executive, as recorded, is Mario Debel. Ceres Pharma offers products and services including Prescription Drugs and Food Supplements. Its focus areas include Traditional Nutraceuticals and Dietary Supplements.
Company details
Ceres Pharma was established in 2017 in Merelbeke, Belgium, within the health and wellness sector. A variety of nutritional supplements is produced and distributed, covering categories like calcium support, joint care, fatigue management, sports nutrition, dietary aids, intestinal health, anti-stress formulas, and skin treatments. Distribution occurs through collaborations with retail outlets. The firm was co-founded by Marc Coucke and Mario Debel, who holds the CEO position.
- Headquarters Merelbeke, Belgium
- Employees 31
- Founders Marc Coucke, Mario Debel
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ceres-pharma.com/en
- Social LinkedIn
- Acquired by Naxicap (Jun 2021)
- Legal Name Ceres Pharma
- Latest Funding Round$197.79K (USD), Grant
Dec 2023
- InvestorsEuropean Union
& 1 more
- Employee Count31
- Investments & AcquisitionsAMNOL
& 3 more
- Acquired byNaxicap
(Jun 2021)
Products & Services of Ceres Pharma
Ceres Pharma offers a comprehensive portfolio of products and services, including Prescription Drugs and Food Supplements.
Development, production, and distribution of prescription drugs for women’s and family health are undertaken by Ceres Pharma
Production and distribution of food supplements and cosmetics for women’s and family health are carried out by Ceres Pharma
Funding Insights of Ceres Pharma
- Total Rounds 1
- Last Round Grant β $197,792
- First Round $197,792
(Dec 2023)
- Investors Count 1
All 1 funding rounds of Ceres Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $197,792 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in Ceres Pharma
Ceres Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in small and medium-sized businesses are managed by Naxicap. | naxicap.com | Frankfurt Am Main, Germany | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Ceres Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ceres Pharma
19 people are tracked at Ceres Pharma (7 in leadership, 12 in team); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
Marc Coucke | Co-Founder | Leadership |
Mario Debel | Co-Founder & CEO | Leadership |
Anja Imschoot | CFO | Leadership |
Chantal Poppe | International Marketing & Communication Director | Leadership |
Mike van Ganse | Chief Operating Officer | Leadership |
Silvia Confalonieri | Head Of Marketing | Leadership |
Bavo Depoortere | International Head Of Graphics & Web | Leadership |
Charlotte Masschelein | Productmanager | Team |
Bram van Peteghem | Corporate Project Manager | Team |
Pieter Vuyge | Corporate Legal Counsel At Ceres Pharma NV | Team |
Bram Verschueren | Business Controller | Team |
Adnan Maghari | Group Business Controller | Team |
Jonas Vandeputte | Brand Assistant Etixx Sports Nutrition | Team |
Herlinde de Spiegeleer | Brand Activator | Team |
Ingrid Lerno | RP GDP | Team |
Cynthia Pots | Supplychain | Team |
Stein Duquet | Finance & Operations Manager | Team |
Arne Aers | Brand Manager | Team |
Niels de Baecke | Trade & Digital Marketing Manager | Team |
Complete people profiles for Ceres Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ceres Pharma
Ceres Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include AMNOL, Aesculapius and Ceumed.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical products, food supplements, and cosmetics are developed and sold. | aesculapius.it | Brescia, Italy | 1959 | Jan 2024 | β’β’β’β’ | |
Dermo-cosmetics products are manufactured by AMNOL in Italy. | amnol.net | Novara, Italy | 1978 | May 2023 | β’β’β’β’ | |
Plant-based healthcare supplements are offered via an online platform. | daciaplant.ro | Brasov, Romania | 2002 | Oct 2022 | β’β’β’β’ | |
| ceumed.com | 0 | Nov 2018 | β’β’β’β’ |
Complete acquisition details for Ceres Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Ceres Pharma
7 dated milestones of Ceres Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Ceres Pharma is founded.
- Acquisition Acquires Ceumed.
- Exit Acquired by Naxicap.
- Acquisition Acquires Dacia Plant.
- Acquisition Acquires AMNOL.
- Funding First funding round of $198K.
- Acquisition Acquires Aesculapius.
Web traffic of Ceres Pharma
The website of Ceres Pharma (ceres-pharma.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 51.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ceres Pharma
Ceres Pharma was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Ceres Pharma is headquartered in Merelbeke, Belgium. It is registered at Merelbeke, East Flanders, Belgium.
Mario Debel is the CEO of Ceres Pharma, as recorded in our data. They have also founded this company.
Ceres Pharma has 31 employees.
Ceres Pharma was established in 2017 in Merelbeke, Belgium, within the health and wellness sector. A variety of nutritional supplements is produced and distributed, covering categories like calcium support, joint care, fatigue management, sports nutrition, dietary aids, intestinal health, anti-stress formulas, and skin treatments. Distribution occurs through collaborations with retail outlets. The firm was co-founded by Marc Coucke and Mario Debel, who holds the CEO position.
Ceres Pharma offers Prescription Drugs and Food Supplements.
Ceres Pharma has made 4 acquisitions, including AMNOL, Aesculapius, and Ceumed.
Ceres Pharma has 2 investors. Key investors include European Union, and Naxicap.
Ceres Pharma operates through Ceres Pharma.
Yes. Ceres Pharma was acquired by Naxicap in June 2021.
